DEBT (Tables)

3 Months Ended

Dec. 31, 2024

Debt Disclosure [Abstract]

Schedule of Long-Term Debt and Effective Interest Rates

Long-term debt as of December 31, 2024 and September 30, 2024 is detailed in the table below.

	December 31, 2024		September 30, 2024
Seller Note – Bolder BioPath (Related party)	$	320	$	376
Seller Note – Preclinical Research Services	—		464
Seller Payable - Orient BioResource Center	3,235		3,700
Seller Note – Histion (Related party)	48		84
Second Lien Notes	19,221		17,846
Convertible Senior Notes	111,551		109,979
Term Loan Facility, DDTL and Incremental Term Loans	272,327		272,840
Total debt before unamortized debt issuance costs	$	406,702	$	405,289
Less: Debt issuance costs not amortized	(10,687)		(11,950)
Total debt, net of unamortized debt issuance costs	$	396,015	$	393,339
Less: Current portion	(3,037)		(3,538)
Total Long-term debt	$	392,978	$	389,801

Below are the weighted-average effective interest rates for the loans available under the Credit Agreement:

	Three Months Ended December 31,
	2024		2023
Effective interest rates:
Term Loan	11.71	%	11.53	%
Initial DDTL	11.69	%	11.51	%
Additional DDTL	11.82	%	11.64	%